PTGX
Protagonist Therapeutics Inc
Price:  
131.62 
USD
Volume:  
708,388.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PTGX Stock Forecast & Price Target

PTGX Stock Price Forecast

The average stock forecast for Protagonist Therapeutics Inc (PTGX) in the next 12 months is 121.30 USD. This price target corresponds to an upside of -7.84%. The range of stock forecasts for PTGX is 101.00 - 143.85 USD. Based on the ratings of 20 analysts, the consensus recommendation for PTGX is BUY.
Target Low Average Median High
Price (USD) 101.00 121.30 120.36 143.85
Upside -23.26% -7.84% -8.55% 9.29%

Recommendation Trends

The latest consensus rating for PTGX is "BUY". This is the average recommendation of 20 analysts: 0 strong sell, 0 sell, 2 hold, 11 buy, 7 strong buy. In the previous period, 19 analysts also majorly recommmended "BUY" for PTGX.

PTGX Financial Stock Forecast

Revenue This Year
553.37M
1,102.56%
from 46.02M
Revenue Next Year
146.89M
-73.46%
from 553.37M
EPS This Year
4.48
-321.52%
from -2.02
EPS Next Year
-1.01
-122.52%
from 4.48